Literature DB >> 34239807

Surveillance, Diagnosis, and Treatment Outcomes of Hepatocellular Carcinoma in Japan: 2021 Update.

Masatoshi Kudo1.   

Abstract

Keywords:  Diagnosis; Hepatocellular carcinoma; Surveillance; Treatment outcomes

Year:  2021        PMID： 34239807      PMCID： PMC8237798          DOI： 10.1159/000516491

Source DB:  PubMed          Journal:  Liver Cancer        ISSN： 1664-5553            Impact factor:   11.740


× No keyword cloud information.
  3 in total

1.  Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis.

Authors:  Toshifumi Tada; Takashi Kumada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Ochi; Satoshi Yasuda; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Noritomo Shimada; Kazuhito Kawata; Takaaki Tanaka; Hideko Ohama; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Michitaka Imai; Atsushi Naganuma; Yohei Koizumi; Shinichiro Nakamura; Kouji Joko; Hiroko Iijima; Yoichi Hiasa
Journal:  Cancer Med       Date:  2022-04-19       Impact factor: 4.711

2.  Management of hepatocellular carcinoma in patients who are 70 years or older.

Authors:  Linda L Wong; Lung Yi Lee; Kameko Karasaki; Makoto Ogihara; Chuong Tran
Journal:  Surg Open Sci       Date:  2022-07-22

3.  Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy.

Authors:  Hidekatsu Kuroda; Takayoshi Oikawa; Masashi Ninomiya; Masashi Fujita; Kazumichi Abe; Kazuo Okumoto; Tomohiro Katsumi; Wataru Sato; Go Igarashi; Chikara Iino; Tetsu Endo; Nobukazu Tanabe; Hiroshi Numao; Shinsaku Fukuda; Katsunori Iijima; Atsushi Masamune; Hiromasa Ohira; Yoshiyuki Ueno; Yasuhiro Takikawa
Journal:  Liver Cancer       Date:  2022-02-15       Impact factor: 12.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.